Assessing the Awareness of Psychotropic Medications Among the Saudi Population: Benefits, Risks, and Prevalence
Anas Alhur(University of Ha'il), Maha AlThawwab(ICU Medical (United States)), Enas Alrkad(Sall Research Medical Center), Afrah Alhur(University of Ha'il), Haya Alrowaebei(Maternity and Children's Hospital), Leen Alshareef(King Khalid University), Mohammad Alfaqeh(Jazan University), Taif Alayyafi(Umm al-Qura University), Rehab Albishi(King Abdullah University Hospital), Noura Harbi(Najran University), Lamah Allehaibi(Umm al-Qura University), Abdulaziz Alosaimi(Taif University), Muteb H. Alshammari(University of Ha'il), Asayel Alamri(Umm al-Qura University), Abdulrahman Mohammed(Ministério da Saúde)
Cited by 2
Related Papers
Redefining Healthcare With Artificial Intelligence (AI): The Contributions of ChatGPT, Gemini, and Co-pilot
|Cureus|2024|73
Paradox of AI in Higher Education: Qualitative Inquiry Into AI Dependency Among Educators in Palestine
|JMIR Medical Education|2025|30
The Acceptance of Digital Health: What about Telepsychology and Telepsychiatry?
|Jurnal Sistem Informasi|2022|27
Exploring Saudi Arabia Individuals' Attitudes toward Electronic Personal Health Records
|Journal of Computer Science and Technology Studies|2022|25
Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries
|The Lancet Global Health|2024|24